Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Phenonet, Inc.

Clinical trials sponsored by Phenonet, Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Can an asthma drug slow ALS? new trial aims to find out Results expected Mar 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

Can an asthma drug slow ALS? new trial aims to find out

Disease control Recruiting now

This phase 2 trial is testing whether an inhaled drug called cromolyn (PHENOGENE-1A) can help people with mild-to-moderate ALS when added to standard care. About 105 participants will receive either a low dose, high dose, or placebo for 24 weeks. Researchers will measure changes …

Phase 2 • Sponsor: PhenoNet, Inc. • Aim: Disease control

Last updated Jul 25, 2026 00:00 UTC